Neoadjuvante Therapiekonzepte beim Zervixkarzinom
Author:
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynaecology
Link
http://link.springer.com/content/pdf/10.1007/s00129-019-4441-7.pdf
Reference18 articles.
1. Nishio S, Kitagawa R et al (2016) Prognostic factors from a randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and cisplatin in metastatic or recurrent cervical cancer: Japan Clinical Oncology Group (JCOG) trial: JCOG0505-S1. Cancer Chemother Pharmacol. https://doi.org/10.1007/s00280-016-3133-4
2. Li WP et al (2015) A clinical Comparison of Lobaplatin or Cisplatin with Mitomycine and Vincristine in Treating Patients with Cervical Squamous Carcinoma. Asian Pac J Cancer Prev 16(11):4629–4631
3. Duan L et al (2017) Effects of neoadjuvant chemotherapy combined with cervical cancer radical surgery for the treatment of cervical cancer. Biomed Res 28:9745–9748
4. Wang N et al (2011) Radiochemotherapy versus radiotherapy in locally advanced cervical cancer: a meta-analysis. Arch Gynecol Obstet 283(1):103–108
5. Lukka H et al (2002) Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer—a meta-analysis. Clin Oncol (R Coll Radiol) 14(3):203–212
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3